Real Peptides CJC-1295 (No DAC) + Ipamorelin

Description

This is a combined research formulation pairing CJC-1295, a synthetic analog of growth hormone-releasing hormone (GHRH), with Ipamorelin, a selective growth hormone secretagogue receptor (GHSR) agonist. It is provided as a combined tool preparation for investigating the interaction of complementary GH-axis signaling mechanisms in experimental designs.

This combination has been examined in preclinical in vitro and rodent model studies of pituitary GH secretion dynamics, the additive effects of GHRH and GHSR pathway activation, IGF-1 axis modulation, and pulsatile GH release characterization. The dual-pathway formulation supports comparative mechanistic studies of the GH axis in laboratory research.

Intended use: In vitro and preclinical in vivo laboratory research only. Not approved for human or veterinary use.